Calyptech conduct a thorough evaluation of critical technologies to ensure a
robust, differentiated and commercially viable solution. We have a solid
track record of successful commercialisation of ground breaking
technologies. This reflects our ability to wholly understand a new
technology, identify key areas of technical risk and assess design and
Whether evaluating in-house technology or looking for a suitable technology
supplier, comparison between competing alternatives is essential to
understanding the value of the technology. This may require assessing the
fit to technical and commercial requirements, or alternatively may result in
finding a new application to better leverage the unique strengths of the
Solid theoretical understanding is fundamental to effective technology
evaluation. Our ability to fully understand the technology enables gaining
maximum potential by optimising performance and establishing metrics for
future performance measurement. Theoretical analysis also provides
invaluable insight into potential limitations and areas of technical risk.
Technical Risk Mitigation
In addition to challenges inherent in any new technology, there can be
significant risk in integrating the technology into a product or system.
Calyptech have a breadth of experience of product delivery in different
technologies and industry domains. This expertise enables us to effectively
identify likely problem areas and mitigate them by design.
In some cases, to mitigate technical risk, early technology prototypes are
useful as a basic proof of technical viability. Calyptech can develop
technology prototypes to verify the technology in the actual problem domain,
or use them as a means to gather key performance metrics.
The outcome of the evaluation and analysis is ultimately to identify a
technology that is differentiated within a specific problem domain, and to
establish reasonable confidence of its commercial viability. When
established early in product development, this knowledge can bring about
significant savings in time and cost.